Exponent/$EXPO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Exponent
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Ticker
$EXPO
Sector
Business services
Primary listing
Employees
958
Headquarters
Website
Exponent Metrics
BasicAdvanced
$3.5B
35.00
$1.99
0.90
$1.16
1.72%
Price and volume
Market cap
$3.5B
Beta
0.9
52-week high
$114.30
52-week low
$63.81
Average daily volume
443K
Dividend rate
$1.16
Financial strength
Current ratio
3.154
Quick ratio
2.984
Long term debt to equity
17.409
Total debt to equity
18.777
Dividend payout ratio (TTM)
58.36%
Profitability
EBITDA (TTM)
124.572
Gross margin (TTM)
35.74%
Net profit margin (TTM)
19.81%
Operating margin (TTM)
22.10%
Effective tax rate (TTM)
27.50%
Revenue per employee (TTM)
$540,000
Management effectiveness
Return on assets (TTM)
9.76%
Return on equity (TTM)
25.05%
Valuation
Price to earnings (TTM)
35
Price to revenue (TTM)
6.872
Price to book
8.22
Price to tangible book (TTM)
8.39
Price to free cash flow (TTM)
29.504
Free cash flow yield (TTM)
3.39%
Free cash flow per share (TTM)
2.361
Dividend yield (TTM)
1.67%
Forward dividend yield
1.72%
Growth
Revenue change (TTM)
2.10%
Earnings per share change (TTM)
-1.93%
3-year revenue growth (CAGR)
4.97%
10-year revenue growth (CAGR)
5.80%
3-year earnings per share growth (CAGR)
1.76%
10-year earnings per share growth (CAGR)
9.96%
3-year dividend per share growth (CAGR)
9.65%
10-year dividend per share growth (CAGR)
15.48%
What the Analysts think about Exponent
Analyst ratings (Buy, Hold, Sell) for Exponent stock.
Bulls say / Bears say
Q2 2025 revenues rose 1% year-over-year to $141.96 million, slightly exceeding prior-year levels and demonstrating stable top-line execution (SEC Form 8-K)
Exponent ended the first half of 2025 with $231.8 million in cash and cash equivalents, zero debt, and returned $64.3 million to shareholders through dividends and repurchases, underpinning strong financial flexibility (SEC Form 8-K)
Management highlighted momentum in early-stage work in digital health, AI usability, and distributed energy systems, positioning Exponent to capture growth in high-potential sectors (SEC Form 8-K)
Exponent’s Q2 net income fell 8.9% year-on-year to $26.6 million and non-GAAP EBITDA margin compressed to 27.8% from 30.2%, signaling pressure on profitability despite revenue stability (SEC Form 8-K)
Revenues in the environmental and health segment declined 4% in Q2 due to softer demand in life sciences and chemical regulatory services, highlighting underperformance in a key business line (SEC Form 8-K)
At a trailing P/E of 53.24×, Exponent trades at a significant premium to peers like FTI Consulting (~22.4×), exposing the stock to multiple contraction risk if growth disappoints (FT.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Sept 2025.
Exponent Financial Performance
Revenues and expenses
Exponent Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept19
Exponent
DividendPayment
$0.30Per share
FAQs
What’s the current market cap for Exponent stock?
Exponent (EXPO) has a market cap of $3.5B as of September 10, 2025.
What is the P/E ratio for Exponent stock?
The price to earnings (P/E) ratio for Exponent (EXPO) stock is 35 as of September 10, 2025.
Does Exponent stock pay dividends?
Yes, the Exponent (EXPO) stock pays dividends to shareholders. As of September 10, 2025, the dividend rate is $1.16 and the yield is 1.72%. Exponent has a payout ratio of 58.36% on a trailing twelve-month basis.
When is the next Exponent dividend payment date?
The next Exponent (EXPO) dividend payment is scheduled for September 19, 2025.
What is the beta indicator for Exponent?
Exponent (EXPO) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.